Abstract
Objectives
Sphincter of Oddi dysfunction (SOD) is a benign pathological syndrome. The clinical manifestations may be a consequence of an anatomical stenosis or sphincter dysmotility. Manometry is invasive and has an associated morbidity. Non-invasive investigations have been evaluated to ameliorate risk but have unknown efficacy. The review aims to critically appraise current evidence for the diagnosis and management of SOD.
Methods
A systematic review of articles containing relevant search terms was performed.
Results
Manometry is the current gold standard in selecting which patients are likely to benefit from endoscopic sphincterotomy (ES). It can, however, be misleading. Several non-invasive investigations were identified. These have poor sensitivities and specificities compared to manometry. There is a paucity of data examining the investigation’s specific ability to select patients for ES. Outcomes of ES for Type I SOD are favourable irrespective of manometry. Types II and III SOD may respond to an initial trial of medical therapy. Manometry may predict response to ES in Type II SOD, but not in Type III.
Conclusions
Non-invasive investigations currently lack sufficient sensitivities and specificities for routine use in diagnosing SOD. Type I SOD should be treated with ES without manometry. Manometry may be useful for Type II SOD. However, whilst data is lacking a therapeutic trial of BotoxTM or trial stenting may bean alternative. Careful and thorough patient counselling is essential. Type III SOD is associated with high complications from manometry and poor outcomes from ES. Alternative diagnoses should be thoroughly sought and its management should be medical.
Similar content being viewed by others
References
Corazziari E, Shaffer EA, Hogan WJ, Sherman S, Toouli J (1999) Functional disorders of the biliary tract and pancreas. Gut 45(Suppl 2):II48–II54
Steinberg WM (1988) Sphincter of Oddi dysfunction: a clinical controversy. Gastroenterology 95(5):1409–1415
Geenen JE, Hogan WJ, Dodds WJ, Toouli J, Venu RP (1989) The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphincter-of-Oddi dysfunction. N Engl J Med 320(2):82–87, Jan 12
Baillie J (2005) Sphincter of Oddi dysfunction: overdue for an overhaul. Am J Gastroenterol 100(6):1217–1220
Toouli J (2005) Biliary scintigraphy versus sphincter of Oddi manometry in patients with post-cholecystectomy pain: is it time to disregard the scan? Curr Gastroenterol Rep 7(2):154–159
Steinberg WM, Salvato RF, Toskes PP (1980) The morphine-prostigmin provocative test—is it useful for making clinical decisions? Gastroenterology 78(4):728–731
Toouli J, Roberts-Thomson IC, Kellow J, Dowsett J, Saccone GT, Evans P et al (2000) Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut 46(1):98–102
Bozkurt T, Orth KH, Butsch B, Lux G (1996) Long-term clinical outcome of post-cholecystectomy patients with biliary-type pain: results of manometry, non-invasive techniques and endoscopic sphincterotomy. Eur J Gastroenterol Hepatol 8(3):245–249
Lobo DN, Takhar AS, Thaper A, Dube MG, Rowlands BJ (2007) The morphine-prostigmine provocation (Nardi) test for sphincter of Oddi dysfunction: results in healthy volunteers and in patients before and after transduodenal sphincteroplasty and transampullary septectomy. Gut 56(10):1472–1473
Madura JA, McCammon RL, Paris JM, Jesseph JE (1981) The Nardi test and biliary manometry in the diagnosis of pancreaticobiliary sphincter dysfunction. Surgery 90(4):588–595
Catalano MF, Lahoti S, Alcocer E, Geenen JE, Hogan WJ (1998) Dynamic imaging of the pancreas using real-time endoscopic ultrasonography with secretin stimulation. Gastrointest Endosc 48(6):580–587
Cavallini G, Rigo L, Bovo P, Brunori MP, Angelini GP, Vaona B et al (1994) Abnormal US response of main pancreatic duct after secretin stimulation in patients with acute pancreatitis of different etiology. J Clin Gastroenterol 18(4):298–303
Darweesh RM, Dodds WJ, Hogan WJ, Geenen JE, Collier BD, Shaker R et al (1988) Efficacy of quantitative hepatobiliary scintigraphy and fatty-meal sonography for evaluating patients with suspected partial common duct obstruction. Gastroenterology 94(3):779–786
Di Francesco V, Brunori MP, Rigo L, Toouli J, Angelini G, Frulloni L et al (1999) Comparison of ultrasound-secretin test and sphincter of Oddi manometry in patients with recurrent acute pancreatitis. Dig Dis Sci 44(2):336–340
Rosenblatt ML, Catalano MF, Alcocer E, Geenen JE (2001) Comparison of sphincter of Oddi manometry, fatty meal sonography, and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi dysfunction. Gastrointest Endosc 54(6):697–704
Warshaw AL, Simeone J, Schapiro RH, Hedberg SE, Mueller PE, Ferrucci JT Jr (1985) Objective evaluation of ampullary stenosis with ultrasonography and pancreatic stimulation. Am J Surg 149(1):65–72
Hadidi A (1983) Pancreatic duct diameter: sonographic measurement in normal subjects. J Clin Ultrasound 11(1):17–22
Gillams AR, Lees WR (2007) Quantitative secretin MRCP (MRCPQ): results in 215 patients with known or suspected pancreatic pathology. Eur Radiol 17(11):2984–2990
Testoni PA, Mariani A, Curioni S, Zanello A, Masci E (2008) MRCP-secretin test-guided management of idiopathic recurrent pancreatitis: long-term outcomes. Gastrointest Endosc 67(7):1028–1034
Pereira SP, Gillams A, Sgouros SN, Webster GJ, Hatfield AR (2007) Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III. Gut 56(6):809–813
Baillie J, Kimberly J (2007) Prospective comparison of secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III. Gut 56(6):742–744
Kalloo AN, Sostre S, Pasricha PJ (1994) The Hopkins scintigraphic score: a non-invasive, highly accurate screening test for SOD. Gastroenterology 106:A342
Sostre S, Kalloo AN, Spiegler EJ, Camargo EE, Wagner HN Jr (1992) A noninvasive test of sphincter of Oddi dysfunction in postcholecystectomy patients: the scintigraphic score. J Nucl Med 33(6):1216–1222
Pineau BC, Knapple WL, Spicer KM, Gordon L, Wallace M, Hennessy WS et al (2001) Cholecystokinin-Stimulated mebrofenin (99mTc-Choletec) hepatobiliary scintigraphy in asymptomatic postcholecystectomy individuals: assessment of specificity, interobserver reliability, and reproducibility. Am J Gastroenterol 96(11):3106–3109
Roberts KJ, Ismail A, Coldham C, Buckels J, Bramhall S (2011) Long-term symptomatic relief following surgical sphincteroplasty for sphincter of Oddi dysfunction. Dig Surg 28(4):304–308
Cicala M, Habib FI, Vavassori P, Pallotta N, Schillaci O, Costamagna G et al (2002) Outcome of endoscopic sphincterotomy in post cholecystectomy patients with sphincter of Oddi dysfunction as predicted by manometry and quantitative choledochoscintigraphy. Gut 50(5):665–668
Thomas PD, Turner JG, Dobbs BR, Burt MJ, Chapman BA (2000) Use of (99 m)Tc-DISIDA biliary scanning with morphine provocation for the detection of elevated sphincter of Oddi basal pressure. Gut 46(6):838–841
Rolny P, Geenen JE, Hogan WJ (1993) Post-cholecystectomy patients with “objective signs” of partial bile outflow obstruction: clinical characteristics, sphincter of Oddi manometry findings, and results of therapy. Gastrointest Endosc 39(6):778–781, Nov-Dec
Sherman S, Troiano FP, Hawes RH, O’Connor KW, Lehman GA (1991) Frequency of abnormal sphincter of Oddi manometry compared with the clinical suspicion of sphincter of Oddi dysfunction. Am J Gastroenterol 86(5):586–590
Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J et al (2006) Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 101(1):139–147
Corazziari E (1999) Biliary tract imaging. Curr Gastroenterol Rep 1:123–131
Dancygier H, Nattermann C (1994) The role of endoscopic ultrasound in biliary tract disease: obstructive jaundice. Endoscopy 26:800–802
Materne R, van Bees BE, Gigont SF et al (2000) Extrahepatic biliary obstruction: magnetic resonance imaging compared with endoscopic ultrasonography. Endoscopy 32:3–9
Kalaitzakis E, Ambrose T, Phillips-Hughes J, Collier J, Chapman RW (2010) Management of patients with biliary sphincter of Oddi disorder without sphincter of Oddi manometry. BMC Gastroenterol 10:124, Oct 22
Khuroo MS, Zargar SA, Yattoo GN (1992) Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial. Br J Clin Pharmacol 33(5):477–485
Cheon YK, Cho YD, Moon JH, Im HH, Jung Y, Lee JS et al (2009) Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction. Gastrointest Endosc 69(6):1111–1116
Vitton V, Delpy R, Gasmi M, Lesavre N, Abou-Berdugo E, Desjeux A et al (2008) Is endoscopic sphincterotomy avoidable in patients with sphincter of Oddi dysfunction? Eur J Gastroenterol Hepatol 20(1):15–21
Sand J, Nordback I, Koskinen M, Matikainen M, Lindholm TS (1993) Nifedipine for suspected type II sphincter of Oddi dyskinesia. Am J Gastroenterol 88(4):530–535
Craig A, Toouli J (2002) Sphincter of Oddi dysfunction: is there a role for medical therapy? Curr Gastroenterol Rep 4(2):172–176
Guelrud M, Rossiter A, Souney PF, Mendoza S, Mujica V (1991) The effect of transcutaneous nerve stimulation on sphincter of Oddi pressure in patients with biliary dyskinesia. Am J Gastroenterol 86(5):581–585
Lee SK, Kim MH, Kim HJ, Seo DS, Yoo KS, Joo YH et al (2001) Electroacupuncture may relax the sphincter of Oddi in humans. Gastrointest Endosc 53(2):211–216
Pasricha PJ, Miskovsky EP, Kalloo AN (1994) Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 35(9):1319–1321
Wehrmann T, Seifert H, Seipp M, Lembcke B, Caspary WF (1998) Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy 30(8):702–707
Rolny P (1997) Endoscopic bile duct stent placement as a predictor of outcome following endoscopic sphincterotomy in patients with suspected sphincter of Oddi dysfunction. Eur J Gastroenterol Hepatol 9(5):467–471
Goff JS (1995) Common bile duct sphincter of Oddi stenting in patients with suspected sphincter dysfunction. Am J Gastroenterol 90(4):586–589
Farup PG, Tjora S (1989) Sphincter of Oddi dysfunction. Dynamic cholescintigraphy and endoscopic retrograde cholangiopancreatography with papillotomy in diagnosis, treatment, and follow-up study. Scand J Gastroenterol 24(8):956–960
Neoptolemos JP, Bailey IS, Carr-Locke DL (1988) Sphincter of Oddi dysfunction: results of treatment by endoscopic sphincterotomy. Br J Surg 75(5):454–459
Botoman VA, Kozarek RA, Novell LA, Patterson DJ, Ball TJ, Wechter DG et al (1994) Long-term outcome after endoscopic sphincterotomy in patients with biliary colic and suspected sphincter of Oddi dysfunction. Gastrointest Endosc 40(2 Pt 1):165–170, Mar-Apr
Fullarton GM, Murray WR (1992) Evaluation of endoscopic sphincterotomy in sphincter of Oddi dysfunction. Endoscopy 24(3):199–202
Lin OS, Soetikno RM, Young HS (1998) The utility of liver function test abnormalities concomitant with biliary symptoms in predicting a favorable response to endoscopic sphincterotomy in patients with presumed sphincter of Oddi dysfunction. Am J Gastroenterol 93(10):1833–1836
Sugawa C, Park DH, Lucas CE, Higuchi D, Ukawa K (2001) Endoscopic sphincterotomy for stenosis of the sphincter of Oddi. Surg Endosc 15(9):1004–1007
Wehrmann T, Wiemer K, Lembcke B, Caspary WF, Jung M (1996) Do patients with sphincter of Oddi dysfunction benefit from endoscopic sphincterotomy? A 5-year prospective trial. Eur J Gastroenterol Hepatol 8(3):251–256
Freeman ML, Gill M, Overby C, Cen YY (2007) Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of oddi dysfunction. J Clin Gastroenterol 41(1):94–102
Rashdan A, Fogel EL, McHenry L Jr, Sherman S, Temkit M, Lehman GA (2004) Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2(4):322–329
Fogel EL, Eversman D, Jamidar P, Sherman S, Lehman GA (2002) Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy 34(4):280–285
Gorelick A, Barnett J, Chey W, Anderson M, Elta G (2004) Botulinum toxin injection after biliary sphincterotomy. Endoscopy 36(2):170–173
Sherman S, Lehman GA, Jamidar P et al (1994) Efficacy of endoscopic spincterotomy and surgical sphincteroplasty for patients with sphincter of oddi dysfunction (SOD): randomised, controlled study. Gastrointest Endosc 40:A125
Gong JQ, Ren JD, Tian FZ, Jiang R, Tang LJ et al (2011) Management of patients with sphincter of Oddi dysfunction based on a new classification. World J Gastroenterol 17(3):385–390
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hall, T.C., Dennison, A.R. & Garcea, G. The diagnosis and management of Sphincter of Oddi dysfunction: a systematic review. Langenbecks Arch Surg 397, 889–898 (2012). https://doi.org/10.1007/s00423-012-0971-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-012-0971-3